FR3145570B1 - Méthode d’identification de composés anti-âge mimétiques de rétinoïdes - Google Patents

Méthode d’identification de composés anti-âge mimétiques de rétinoïdes

Info

Publication number
FR3145570B1
FR3145570B1 FR2301014A FR2301014A FR3145570B1 FR 3145570 B1 FR3145570 B1 FR 3145570B1 FR 2301014 A FR2301014 A FR 2301014A FR 2301014 A FR2301014 A FR 2301014A FR 3145570 B1 FR3145570 B1 FR 3145570B1
Authority
FR
France
Prior art keywords
aging
identifying
retinol
derivatives
retinoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2301014A
Other languages
English (en)
Other versions
FR3145570A1 (fr
Inventor
Nukhet Cavusoglu
Kahina Abed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR2301014A priority Critical patent/FR3145570B1/fr
Publication of FR3145570A1 publication Critical patent/FR3145570A1/fr
Application granted granted Critical
Publication of FR3145570B1 publication Critical patent/FR3145570B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cosmetics (AREA)

Abstract

Méthode d’identification de composés anti-âge mimétiques de rétinoïdes La présente invention concerne un procédé d’identification d’un composé anti-âge ayant une action mimétique de l’acide rétinoïque, du rétinol ou d’un de leurs dérivés. Elle a également pour objet l’utilisation cosmétique d’au moins un composé anti-âge ayant une action mimétique de l’acide rétinoïque, du rétinol ou d’un de leurs dérivés, identifié par un tel procédé, pour prévenir et/ou traiter le vieillissement cutané. Elle a également pour objet une méthode d’évaluation de l’efficacité d’une composition cosmétique comprenant à titre d’agent actif du rétinol, de l’acide rétinoïque, l’un de leurs dérivés ou un composé anti-âge identifié par un tel procédé. Figure pour l'abrégé : néant
FR2301014A 2023-02-03 2023-02-03 Méthode d’identification de composés anti-âge mimétiques de rétinoïdes Active FR3145570B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR2301014A FR3145570B1 (fr) 2023-02-03 2023-02-03 Méthode d’identification de composés anti-âge mimétiques de rétinoïdes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2301014 2023-02-03
FR2301014A FR3145570B1 (fr) 2023-02-03 2023-02-03 Méthode d’identification de composés anti-âge mimétiques de rétinoïdes

Publications (2)

Publication Number Publication Date
FR3145570A1 FR3145570A1 (fr) 2024-08-09
FR3145570B1 true FR3145570B1 (fr) 2026-01-30

Family

ID=86852066

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2301014A Active FR3145570B1 (fr) 2023-02-03 2023-02-03 Méthode d’identification de composés anti-âge mimétiques de rétinoïdes

Country Status (1)

Country Link
FR (1) FR3145570B1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101886342B1 (ko) * 2010-11-30 2018-08-10 (주)아모레퍼시픽 피부 노화와 관련된 유전자 및 피부 노화를 방지하는 물질을 스크리닝하는 방법
FR3034662B1 (fr) * 2015-04-10 2020-08-28 Isp Investments Inc Nouvelles utilisations du peptide de sequence his-d-trp-ala-trp-d-phe-lys-nh2 pour diminuer ou retarder l'apparition de la senescence cellulaire et des signes du vieillissement cutane
FR3088075A1 (fr) * 2018-11-06 2020-05-08 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Procede pour evaluer la capacite d'une substance ou d'une composition a prevenir, ralentir ou eliminer les signes du vieillissement de la peau ou des levres
JP7633003B2 (ja) * 2019-11-29 2025-02-19 ポーラ化成工業株式会社 抗老化成分のスクリーニング方法

Also Published As

Publication number Publication date
FR3145570A1 (fr) 2024-08-09

Similar Documents

Publication Publication Date Title
DE60216944D1 (de) Mikrobizide formulierung die essentielle öle oder deren derivate enthält
CL2021002681A1 (es) Inhibidores de la dihidroorotato deshidrogenasa.
MA29159B1 (fr) Melanges fongicides
DOP2011000044A (es) Metodos para tratar la talasemia
MA35012B1 (fr) Composition phytosanitaire comprenant des huiles essentielles renforçant l'activité anti-fongique
BRPI0417104A (pt) composto, processo para a preparação de um composto, composição fungicida e método para o combate preventivo ou curativo de fungos fitopatogênicos de plantações
FR3088548B1 (fr) Composition comprenant un derive d’acide cinnamique et un polymere cellulosique non ionique non associatif
UY40172A (es) Combinaciones, mezclas y composiciones fungicidas y usos de las mismas
MA31835B1 (fr) Utilisation de solutions d'huile de menthe ou de l-carvone pour le traitement fongicide et/ou antigerminatif des bulbes et/ou tubercules
BRPI0508738A (pt) compostos, processo para a preparação de um composto, composição fungicida e método para combater de maneira preventiva ou curativa os fungos fitopatogênicos de plantações
MX2024012189A (es) Composiciones para el cuidado de la piel que comprenden vitamina e y vitamina b3
MA35336B1 (fr) Bloqueurs des canaux sodiques voltage-dependants
FR3145570B1 (fr) Méthode d’identification de composés anti-âge mimétiques de rétinoïdes
BRPI0414822A (pt) método de inibir a produção de lipoproteìna remanescente
MA32243B1 (fr) Composition bactéricide destinée à l'agriculture et à l'horticulture et procédé de prévention contre les maladies des plantes
CL2021002555A1 (es) Composiciones antifúngicas.
FR3109301B1 (fr) Principe actif comprenant un extrait particulier de punica granatum et utilisations pour prevenir et/ou lutter contre l’acne
FR3088803B1 (fr) Nouvelle composition pour la défense des plantes contre des agents pathogènes
FR3125718B1 (fr) Principe actif comprenant des oligo-glucanes issus de la fraction cytosolique de Saccharomyces cerevisiae et ses utilisations cosmétiques
FR3111075B1 (fr) Composition à base de rétinol
FR3102362B1 (fr) Composition alcaline comprenant au moins trois agents alcalins differents pour le traitement des fibres keratiniques, procedes et utilisations
FR3133758B1 (fr) Extrait de Spirodela polyrhiza et ses utilisations cosmétiques
FR3120872B1 (fr) Composition à base de monomères ( méth )acrylate
CO2021015286A2 (es) Agente de control de nematodos parasitarios de plantas y método para controlar nematodos parasitarios de plantas
EP4265277A4 (fr) Composition pour prévenir ou traiter le glioblastome comprenant un complexe d'acides nucléiques peptidiques en tant que principe actif

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20240809

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4